Research Area / Fields

  1. Cancer patient response to immunotherapy
  2. Genotype-phenotype relations in cancer
  3. Somatic clonality in normal tissues and its relation to tumor development
bio

Short Bio

Dr. Keren Yizhak leads the Computational Cancer Genomics Lab at the Faculty of Medicine, where her research focuses on developing and applying computational tools to study cancer genomics and immunity.

Dr. Yizhak completed her undergraduate studies in Computational Biology and Computer Science at the Hebrew University of Jerusalem. She then pursued her M.Sc. and Ph.D. in Computer Science at Tel Aviv University, where she specialized in computational methods for studying human metabolism in aging and cancer.

In 2015, she began her postdoctoral fellowship at the Broad Institute of MIT and Harvard, working with Prof. Gad Getz. During her time there, she developed methods for studying tumor immunity at the single-cell level and tools for analyzing somatic clonality in normal tissues.

In 2019, Dr. Yizhak established her independent lab, continuing her mission to advance computational approaches for unraveling the complexities of cancer biology and immune interactions.

Her work bridges computational innovation and biomedical discovery, contributing valuable insights into cancer progression, immune responses, and therapeutic strategies.

Available Technologies for commercialization

arrow Business Development Contacts
Dr. Mor Goldfeder
Director of Business Development, Life Sciences